Completed PHASE4 INTERVENTIONAL 2-arm NCT00161577

Use of Ketorolac in Management of Post-Operative Pain After Heart Surgery

Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety and Efficacy of Ketorolac in the Management of Post-Operative Pain After Heart Surgery

Sponsor: Weill Medical College of Cornell University

Conditions Pain Management Following Cardiopulmonary Bypass Surgery

Interventions Ketorolac Placebo

Updated 5 times since 2017 Last updated: May 12, 2009 Started: Jan 31, 2004 Primary completion: Jun 30, 2006 Completion: Jun 30, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Pain Management Following Cardiopulmonary Bypass Surgery and is currently completed. Weill Medical College of Cornell University leads this study, which shows 5 recorded versions since 2004 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jan 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Weill Medical College of Cornell University

Data source: Weill Medical College of Cornell University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States